SEC Form 4 · accession 0001127602-19-008320
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Birgit Girshick
Officer — Corporate Executive VP
Period of report
Feb 22, 2019
Accepted (ET)
Feb 26, 2019 · 2:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2019 | A | 2,775 | $0.00 | A | 24,960 | D | |
| Common Stock | Feb 23, 2019 | F | 316 | $144.67 | D | 24,644 | D | |
| Common Stock | Feb 24, 2019 | F | 322 | $144.67 | D | 24,322 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $144.67 | Feb 22, 2019 | A | 11,832 | A | Feb 22, 2020 | Feb 22, 2024 | Common Stock | 11,832 | 11,832 | D |
Explanation of responses
- F1Consists of 2,775 unvested restricted stock units that vest as follows: 693 shares vest one (1) year from the date of issuance, 694 shares vest two (2) years from the date of issuance, 694 shares vest three (3) years from the date of issuance, and 694 shares vest four (4) years from the date of issuance.
- F2Stock options vest equally over four (4) years beginning one year from date of grant.